S
Spero Therapeutics, Inc. (SPRO)
NMS – Real vaqt narxi. Valyuta: USD
1.19
-0.04 (-3.25%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
1.21
+0.02 (1.68%)
Bozordan keyin: Aug 12, 2026, 6:40 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
1.19
-0.04 (-3.25%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
1.21
+0.02 (1.68%)
Bozordan keyin: Aug 12, 2026, 6:40 PM EDT
Spero Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda ko'p dorilarga chidamli (MDR) bakterial infektsiyalar va kam uchraydigan kasalliklar uchun yangi davolash usullarini aniqlash va ishlab chiqishga qaratilgan. Kompaniyaning mahsulot nomzodlari orasida kattalar bemorlarda pielonefritni o'z ichiga olgan murakkab siydik yo'llari infektsiyalarini davolash uchun og'iz orqali qabul qilinadigan karbapenem sinfidagi antibiotik bo'lgan Tebipenem HBr (tebipenem pivoxil hydrobromide) mavjud bo'lib, uning ikkinchi III bosqich sinovi yakunlangan. Kompaniya tebipenem pivoxil va tebipenem HBrni ishlab chiqish, ishlab chiqarish va tijoratlashtirish bo'yicha Meiji Seika Pharma Co., Ltd. bilan; va Xitoy, Janubiy Koreya va Janubi-Sharqiy Osiyo mamlakatlarida SPR206ni ishlab chiqish, ishlab chiqarish va tijoratlashtirish bo'yicha Everest Medicines bilan litsenziya shartnomasiga ega. Spero Therapeutics, Inc. 2013-yilda tashkil etilgan va shtab-kvartirasi Massachusets shtatining Kembrij shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Debra Jeske Zack M.D., Ph.D. | Chief Medical Officer |
| Mr. John Raymond | Senior Vice President of Finance & Business Operations |
| Mr. Timothy Keutzer | Chief Operating Officer |
| Ms. Esther P. Rajavelu | CEO, President, CFO, Chief Business Officer, Treasurer & Director |
| Ms. Sheila Finan | Senior VP & Controller |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-14 | 8-K | d320658d8k.htm |
| 2026-06-25 | 8-K | d86736d8k.htm |
| 2026-06-23 | S-8 | d155753ds8.htm |
| 2026-06-22 | 8-K | d51395d8k.htm |
| 2026-05-13 | 8-K | d147628d8k.htm |
| 2026-05-13 | 10-Q | spro-20260331.htm |
| 2026-04-27 | DEFA14A | d120525ddefa14a.htm |
| 2026-04-27 | DEF 14A | d45106ddef14a.htm |
| 2026-04-27 | ARS | d22424dars.pdf |
| 2026-04-13 | PRE 14A | d45106dpre14a.htm |